SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas

Tanaka, I; Dayde, D; Tai, MC; Mori, H; Solis, LM; Tripathi, SC; Fahrmann, JF; Unver, N; Parhy, G; Jain, R; Parra, ER; Murakami, Y; Aguilar-Bonavides, C; Mino, B; Celiktas, M; Dhillon, D; Casabar, JP; Nakatochi, M; Stingo, F; Baladandayuthapani, V; Wang, H; Katayama, H; Dennison, JB; Lorenzi, PL; Do, KA; Fujimoto, J; Behrens, C; Ostrin, EJ; Rodriguez-Canales, J; Hase, T; Fukui, T; Kajino, T; Kato, S; Yatabe, Y; Hosoda, W; Kawaguchi, K; Yokoi, K; Chen-Yoshikawa, TF; Hasegawa, Y; Gazdar, AF; Wistuba, II; Hanash, S; Taguchi, A

Taguchi, A (通讯作者),Aichi Canc Ctr, Div Mol Diagnost, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022; 114 (2): 290

Abstract

Background Approximately 20% of lung adenocarcinoma (LUAD) is negative for the lineage-specific oncogene Thyroid transcription factor 1 (TTF-1) and ex......

Full Text Link